Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Eloralintide And Tirzepatide

AMPLIFY-1

Eli Lilly · Phase 3 · Not yet recruiting · Enrollment 2115

NCT07881432

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
EloraTZP Dose 1n/rn/rn/rn/rn/r
EloraTZP Dose 2n/rn/rn/rn/rn/r
EloraTZP Dose 3n/rn/rn/rn/rn/r
EloraTZP Dose 4n/rn/rn/rn/rn/r
EloraTZP Dose 5n/rn/rn/rn/rn/r
Tirzepatiden/rn/rn/rn/rn/r
Eloralintiden/rn/rn/rn/rn/r
Placebon/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.